Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (321-330 of 495) with videos related to

Pageof 50
Sort By:
International Journal of Cancer|February 14, 2014
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerMartina Kluth, Silvia Harasimowicz, Lia Burkhardt, et al.
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
The Prostate|September 21, 2017
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancerChristoph Burdelski, Rami Shihada, Andrea Hinsch, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
Annals of Surgical Oncology|April 22, 2022
Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive LymphocytesChristoph Fraune, Eike Burandt, Ronald Simon, et al.
Scientific Reports|June 4, 2020
Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancersAndreas Marx, Aljoscha Schumann, Doris Höflmayer, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 15, 2025
Identification and characterization of tumor and stromal derived liquid biopsy analytes in pancreatic ductal adenocarcinomaJulian Götze, Kira Meißner, Thais Pereira-Veiga, et al.
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
Human Pathology|May 13, 2022
Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathologyViktor Reiswich, Gonca Akdeniz, Maximilian Lennartz, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Pageof 50

Showing results (321-330 of 495) with videos related to

Sort By:
Pageof 50
International Journal of Cancer|February 14, 2014
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerMartina Kluth, Silvia Harasimowicz, Lia Burkhardt, et al.
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
The Prostate|September 21, 2017
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancerChristoph Burdelski, Rami Shihada, Andrea Hinsch, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
Annals of Surgical Oncology|April 22, 2022
Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive LymphocytesChristoph Fraune, Eike Burandt, Ronald Simon, et al.
Scientific Reports|June 4, 2020
Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancersAndreas Marx, Aljoscha Schumann, Doris Höflmayer, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 15, 2025
Identification and characterization of tumor and stromal derived liquid biopsy analytes in pancreatic ductal adenocarcinomaJulian Götze, Kira Meißner, Thais Pereira-Veiga, et al.
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
Human Pathology|May 13, 2022
Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathologyViktor Reiswich, Gonca Akdeniz, Maximilian Lennartz, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Pageof 50